|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/14 | (2015.01) |
| A61K 35/14 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 38/17 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) |
| (11) | Number of the document | 2793913 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12859136.9 |
| Date of filing the European patent application | 2012-11-02 | |
| (97) | Date of publication of the European application | 2014-10-29 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2012/001345 |
| Date | 2012-11-02 |
| (87) | Number | WO 2013/090978 |
| Date | 2013-06-27 |
| (30) | Number | Date | Country code |
| 2011905368 | 2011-12-21 | AU |
| (72) |
RAYNER, Craig , AU
|
| (73) |
CSL Limited ,
655 Elizabeth Street, Melbourne VIC 3000,
AU
|
| (54) | DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS |
| DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS |